AVORO CAPITAL ADVISORS LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | ALKS | 2.24M | $67.20M |
 | UTHR | 2.02M | $847.74M |
 | MLTX | 2.00M | $14.34M |
 | MDGL | 1.83M | $840.72M |
 | SEPN | 1.34M | $25.16M |
 | ORKA | 1.33M | $25.64M |
 | BCRX | 1.25M | $9.49M |
 | ARGX | 990K | $730.18M |
 | TNGX | 545K | $4.58M |
Alkermes plc
ALKS
Shares Held
2.24M
Value
$67.20M
United Therapeutics Corporation
UTHR
Shares Held
2.02M
Value
$847.74M
MoonLake Immunotherapeutics
MLTX
Shares Held
2.00M
Value
$14.34M
Madrigal Pharmaceuticals, Inc.
MDGL
Shares Held
1.83M
Value
$840.72M
Septerna, Inc.
SEPN
Shares Held
1.34M
Value
$25.16M
Oruka Therapeutics, Inc.
ORKA
Shares Held
1.33M
Value
$25.64M
BioCryst Pharmaceuticals, Inc.
BCRX
Shares Held
1.25M
Value
$9.49M
argenx SE
ARGX
Shares Held
990K
Value
$730.18M
Tango Therapeutics, Inc.
TNGX
Shares Held
545K
Value
$4.58M